Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Market Access
  • Medicare Advantage Insurers Will See Higher Payments as CMS Backs Off a Key Payment Update
  • Market Access

Medicare Advantage Insurers Will See Higher Payments as CMS Backs Off a Key Payment Update

KFF Medicare

The Trump administration this week backed off a key element of its Medicare Advantage rate proposal, resulting in billions of dollars in additional payments to private insurers.

Market AccessRead full story

pharminent April 8, 2026 (Last updated: April 8, 2026)

KFF Medicare

The Trump administration this week backed off a key element of its Medicare Advantage rate proposal, resulting in billions of dollars in additional payments to private insurers.

Market AccessRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Sidewinder pockets $137m in Series B to take bispecific ADCs to clinic
Next: Gilead Less M&A Happy Now but Door Still Open for ‘Compelling’ Opportunities

Related Stories

  • Market Access

GSK’s Nucala secures NICE COPD endorsement

pharminent May 29, 2026
  • Market Access

Medicare Advantage Out-of-Pocket Limits: Variation and Trends

pharminent May 28, 2026
  • Market Access

France ‘first EU country to cover obesity drugs’

pharminent May 28, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.